Family offices investing in life sciences. .

Family offices investing in life sciences. Aug 1, 2025 · This list includes 280 single family offices from our global single family office database that mention biotech keywords on their website. Many family offices thereof are actively investing in biotech and life sciences startups and firms. Axial’s lower middle market M&A directory includes information on 76 Life Sciences Family Offices. May 15, 2023 · The recent increase in healthcare investment by family offices comes despite the sector’s difficulties in the public markets, where it has suffered from the general move out of growth stocks. Aug 15, 2024 · Family offices are emerging as influential investors in the early-stage life sciences sector, leveraging their unique position to support innovation while seeking promising financial returns. The Axial Directory can help you identify Life Sciences Family Offices and other participants active in the lower middle market M&A economy today. Behind each firm is a strategy, and Mergr gives professionals structured access to firm profiles, portfolio companies, and investment history across the private equity landscape. Aug 21, 2025 · Investment in life sciences – healthcare, biotech, medical equipment – remains the most popular direct investment option for family offices, with more than double the amount invested in fintech/finance, the next most popular choice, according to data from FamCap Analytics. . tiqdie kduzulc jndc ayxlljiv rirsode comk lae qgoj ragtn srrb